 Products |
 Benzene, [[2-(bromomethyl)-3-methylbutoxy]methyl]-, (S)- |
| Propanamide, 3-amino-2,2-dimethyl- |
| (2S,4E)-5-Chloro-N,N-dimethyl-2-(1-methylethyl)-4-pentenamide |
| Benzene, 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)- |
| Benzene, 4-[2-(bromomethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)-, (R)- |
| Benzenepentanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-4-methoxy-3-(3-methoxypropoxy)- γ-(1-methylethyl)-, methyl ester, (αS,γS)- |
| Carbamic acid, [(1S,3S)-1-(hydroxymethyl)-3-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methylpentyl]-, 1,1-dimethylethyl ester |
| Carbamic acid, N-[(1S,2S,4S)-2-hydroxy-1-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-5-methyl-4-[(phenylmethoxy)methyl]hexyl]-, 1,1-dimethylethyl ester |
| 5-Oxazolidinepropanoic acid, 3-[(1,1-dimethylethoxy)carbonyl]-4-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-2,2-dimethyl-α-(1-methylethyl)-, (αS,4S,5S)- |
| 2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)- |
| Aliskiren Base |
| Aliskiren Hemifumarate |
| 3-Azetidinepropanoic acid, 1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-, methyl ester, (3R,4S)- |
| 3-Azetidinepropanoic acid, 1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-, (3R,4S)- |
| 2-Azetidinone, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(phenylmethoxy)phenyl]-, (3R,4S)- |
| 2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-, (3R,4S)- |
| 2-Oxazolidinone, 3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-phenyl-, (4S)- |
| 2-Oxazolidinone, 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4S)- |
| 2-Oxazolidinone, 3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-, (4S)- |
| 2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-[(trimethylsilyl)oxy]propyl]-4-[4-[(trimethylsilyl)oxy]phenyl]-, (3R,4S)- |
| Ezetimibe |
| Alanine, N-2-pyridinyl-, ethyl ester |
| Glycine, N-(4-cyanophenyl)- |
| Carbonochloridic acid, hexyl ester |
| Glycine, N-(4-cyanophenyl)-, ethyl ester |
| Benzoic acid, 4-chloro-3-nitro- |
| Benzoic acid, 4-(methylamino)-3-nitro- |
| Benzoyl chloride, 4-(methylamino)-3-nitro- |
| Alanine, N-[4-(methylamino)-3-nitrobenzoyl]-N-2-pyridinyl-, ethyl ester |
| Alanine, N-[3-amino-4-(methylamino)benzoyl]-N-2-pyridinyl-, ethyl ester |
| Alanine, N-[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester |
| Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester |
| Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester |
| Methanesulfonamide, N-[4-(4-fluorophenyl)-5-(hydroxymethyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl- |
| Methanesulfonamide, N-[5-(bromomethyl)-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl- |
| Phosphonium, [[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]methyl]triphenyl-, bromide |
| Methanesulfonamide, N-[5-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl- |
| Methanesulfonamide, N-[4-(4-fluorophenyl)-5-formyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl- |
| tert-Butyl (4R-Cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate |
| D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, 1,1-dimethylethyl ester |
| L-erythro-Hexuronic acid, 3,5-dideoxy-2,4-O-(1-methylethylidene)-, 1,1-dimethylethyl ester |
| Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanate |
| 1,3-Dioxane-4-acetic acid,6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6S)- |
| Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-hydroxy-5-oxo-(E)-6-heptenate |
| Rosuvastatin Methyl Ester |
| Rosuvastatin tert-Butyl Ester |
| Rosuvastatin Ethyl Ester |
| Rosuvastatin Acid |
| Rosuvastatin Lactone |
| Rosuvastatin Methanamine Salt |
| Rosuvastatin Sodium |
| Rosuvastatin Calcium |
| Rosuvastatin Calcium (Amorphous) |
| Rosuvastatin Calcium (Form A) |
| 2-Cyclopropyl-3-hydroxymethyl-
4-(4-fluorophenyl)quinoline |
| Diphenyl [2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]methylphosphine oxide |
| 3-Quinolinecarboxaldehyde, 2-cyclopropyl-4-(4-fluorophenyl)- |
| (E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quin-olinyl]-2-propenal |
| 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-, ethyl ester, (E)- |
| 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, ethyl ester, (3R,5S,6E)-rel- |
| t-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate |
| Pitavastatin tert-Butyl Ester |
| 5-Oxo-Pitavastatin Methyl Ester |
| Pitavastatin Methyl Ester |
| Pitavastatin Lactone |
| Pitavastatin Ethyl Ester |
| Pitavastatin Methanamine Salt |
| Pitavastatin Acid |
| Pitavastatin Sodium |
| Pitavastatin Calcium |
| Pitavastatin Calcium (Amorphous) |
| Pitavastatin Calcium (Form Ⅰ) |
| 4-Fluoro-α-[2-methyl-1-oxopropyl]-γ-oxo-N, β- diphenylbenzenebutaneamide |
| (4R,Cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
| (4R,Cis)-1,1-dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
| (4R-cis)-1,1-Dimethylethyl- 6-[2-[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate |
| Atorvastatin tert-Butyl Ester |
| Atorvastatin Methyl Ester |
| Atorvastatin Acid |
| Atorvastatin Lactone |
| Atorvastatin Methanamine Salt |
| Atorvastatin Sodium |
| Atorvastatin Calcium |
| Atorvastatin Calcium （Amorphous） |
| Atorvastatin Calcium (Form Ⅰ) |
| Atorvastatin Calcium (Form Ⅷ) |
| Benzenepropanoic acid, β-amino-, hydrochloride, (βS)- |
| Benzenepropanol, γ-amino-, (S)- |
| Benzenepropanol, γ-(dimethylamino)-,(S)- |
| Benzenepropanol, γ-(dimethylamino)-, (±)- |
| DL-Dapoxetine |
| Dapoxetine free base |
| Dapoxetine Hydrochloride |
| Lithium diisopropylamide |
| Diethylmethoxyborane in THF |
| Sodium bis(trimethylsilyl)amide in THF |
| Butyllithium in hexane |
| 2-Oxazolidinone, 4-phenyl-, (S)- |
| (R)-(+)-2-Methyl-CBS-oxazaborolidine |
| 2-Oxazolidinone, 3-(3-methyl-1-oxobutyl)-4-(phenylmethyl)-, (R)- |
| Pyrazine, 2,5-dihydro-3,6-diethoxy-2-(1-methylethyl)-, (R)- |
| (S)-((2-溴甲基-3-甲基丁氧基)甲基)苯 |
| 3-氨基-2,2-二甲基-丙酰胺 |
| (2S,4E)-5-氯-N,N-二甲基-2-异丙基-4-戊酰胺 |
| (R)-[2-氯甲基-3-甲基丁基]-1-甲氧基-2-(3-甲氧基丙氧基)苯 |
| (R)- 4-[2-溴甲基-3-甲基丁基]-1-甲氧基-2-(3-甲氧基丙氧基)苯 |
| (αS,γS)- α-[[(叔丁氧基)羰基]氨基]-4-甲氧基-3-(3-甲氧基丙氧基)- γ-异丙基苯戊酸甲酯 |
| [(1S,3S)-1-(羟甲基)-3-[[4-甲氧基-3-(3-甲氧基丙氧基)苯基]甲基]-4-甲基戊基]氨基甲酸叔丁酯 |
| N-[(1S,2S,4S)-2-羟基-1-[(2S)-2-[[4-甲氧基-3-(3-甲氧基丙氧基)苯基]甲基]-3-甲基丁基]-5-甲基-4-[(苯甲氧基)甲基]己基]-氨基甲酸叔丁酯 |
| (αS,4S,5S)- 3-[(叔丁氧基)羰基]-4-[(2S)-2-[[4-甲氧基-3-(3-甲氧基丙氧基)苯基]甲基]-3-甲基丁基]-2,2-二甲基-α-异丙基-5-噁唑烷丙酸 |
| (3S,5S)-5-[(1S,3S)-1-叠氮基-3-[[4-甲氧基-3-(3-甲氧基丙氧基)苯基]甲基]-4-苄基]二氢-3-异丙基-2(3H)-呋喃酮, |
| 阿利克仑游离碱 |
| 阿利克仑半富马酸盐 |
| (3R,4S)-3-(3-[2-氧代-4-（苄氧苯基）-1-（4-氟苯基）-氮杂环丁烷基])丙酸甲酯 |
| (3R,4S)-3-(3-[2-氧代-4-（苄氧苯基）-1-（4-氟苯基）-氮杂环丁烷基])丙酸 |
| (3R,4S)-1-(4-氟苯基)-3-[3-氧代 -3-(4 氟苯基)丙基]-4-(4-苄氧苯基)-2-氮杂环丁酮 |
| (3R,4S)-1-(4-氟苯基)-3-[(3S)-3-(4-氟苯基)-3-羟丙基]-4-(4-苄氧苯基)-2-氮杂环丁酮 |
| (4S)-3-[5-(4-氟苯基)-1,5-氧代戊基]-4-苯基-2-噁唑烷酮 |
| (4S)-3-[(5S)-5-(4-氟苯基)-5-羟基-1-氧代戊基]-4-苯基-2-噁唑烷酮 |
| (4S)-3-{(2R,5S)-5-(4-氟苯基)-2-[(S)-(4-氟苯基)氨基][4-(三甲基硅氧基)苯基]甲基}-1-氧代-(5-三甲基硅氧基) 戊基]-4-苯基-2-噁唑烷酮 |
| (3R,4S)-1-(4-氟苯基)-3-[(3S)-3-(4-氟苯基)-3-三甲硅氧基丙基]-4-(4-三甲硅氧苯基)-2-氮杂环丁酮 |
| 依替米贝 |
| N-2-吡啶基-b-丙氨酸乙酯 |
| N-(4-氰基苯基)氨基乙酸 |
| 氯甲酸正己酯 |
| N-(4-氰基苯基)氨基乙酸乙酯 |
| 4-氯-3-硝基苯甲酸 |
| 4-甲胺基-3-硝基苯甲酸 |
| 4-甲胺基-3-硝基苯甲酰氯 |
| N-[4-甲胺基-3-硝基苯酰基]N-2-吡啶基-b-丙氨酸乙酯 |
| N-[4-甲胺基-3-氨基苯酰基]N-2-吡啶基-b-丙氨酸乙酯 |
| N-[[2-[[(4-氰基苯)胺]甲基]-1甲基-1H-5-苯并咪唑]羰基]3-氨基苯酰基]N-2-吡啶基-b-丙氨酸乙酯 |
| N-[[2-[[[(4-(氨基亚胺甲基)苯基]胺基]甲基]-1甲基-1H-5-苯并咪唑]羰基]N-2-吡啶基-b-丙氨酸乙酯 |
| 达比加群酯 |
| N-[4-(4-氟苯基)-5-羟甲基-6-异丙基-2-嘧啶基]-N-甲基甲磺酰胺 |
| N-[4-(4-氟苯基)-5-溴甲基-6-异丙基-2-嘧啶基]-N-甲基甲磺酰胺 |
| [4-(4-氟苯基)-6-异丙基-2-(N-甲基-N-甲磺酰胺基)-5-嘧啶基]三苯基溴化膦 |
| N-[4-(4-氟苯基)-5-(二苯基氧膦基)甲基-6-异丙基-2-嘧啶基]-N-甲基甲磺酰胺基 |
| N-[4-(4-氟苯基)-5-甲醛基-6-异丙基-2-嘧啶基]-N-甲基甲磺酰胺 |
| (4R-cis)-6-乙酰氧甲基- -2,2二甲基-1,3-二氧六环-4-乙酸叔丁酯 |
| (4R-cis)-6-羟甲基-2,2二甲基-1,3-二氧六环-4-乙酸叔丁酯 |
| (4R-cis)-6-甲醛基-2,2二甲基-1,3-二氧六环-4-乙酸叔丁酯 |
| (3R)-叔丁基二甲硅氧基-5-氧代-6-三苯基磷烯己酸甲酯 |
| (4R,6S)-6-[(1E)-2-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰)氨基]-5-嘧啶]乙烯基]-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯 |
| (3R、5S、6E)-7-[4-(4-氟苯基)-6-异丙基-2-(N-甲基甲磺酰基胺基-5-嘧啶)]-3-羟基-5-氧代-6-庚烯酸甲酯 |
| 瑞舒伐他汀甲酯 |
| 瑞舒伐他汀叔丁酯 |
| 瑞舒伐他汀乙酯 |
| 瑞舒伐他汀酸 |
| 瑞舒伐他汀内酯 |
| 瑞舒伐他汀甲胺盐 |
| 瑞舒伐他汀钠 |
| 瑞舒伐他汀钙 |
| 瑞舒伐他汀钙(无定形) |
| 瑞舒伐他汀钙(晶型A) |
| 2-环丙基-4-（4-氟苯基）-3-喹啉甲醇 |
| [2-环丙基-4-（4-氟苯基）-3-喹啉基]甲基二苯基氧磷 |
| 2-环丙基-4-（4-氟苯基）-3-喹啉甲醛 |
| (E)-3-[2-环丙基-4-(4-氟苯基)-3-喹啉-2-丙烯醛 |
| (E)-7-[2-环丙基-4-(4-氟苯)-3-喹啉基]-5-羟基-3-氧代-6-庚烯酸乙酯 |
| (3R,5S,6E)-rel-7-[2-环丙基-4-(4-氟苯)-3-喹啉基]-3,5-二羟基-6-庚烯酸乙酯 |
| 6-[[(1E)-2-环丙基-4-(4-氟苯基)-3-喹啉基]-乙烯基]-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯 |
| 匹伐他汀叔丁酯 |
| 5-氧代匹伐他汀甲酯 |
| 匹伐他汀甲酯 |
| 匹伐他汀内酯 |
| 匹伐他汀乙酯 |
| 匹伐他汀甲胺盐 |
| 匹伐他汀酸 |
| 匹伐他汀钠 |
| 匹伐他汀钙 |
| 匹伐他汀钙无定形 |
| 匹伐他汀钙晶型Ⅰ |
| 4-氟-α-[2-甲基-1-氧丙基]-γ -氧代-N,β-二苯基苯丁酰胺 |
| (4R-cis)-6-氰甲基-2,2-二甲基-1,3-二氧戊环-4-乙酸叔丁酯 |
| (4R-cis)-6-氨乙基-2,2-二甲基-1,3-二氧六环-4-乙酸叔丁酯 |
| (4R-cis)-6-[2-[2-(4-氟苯基)-5-(1-异丙基)-3-苯基-4-[(苯胺)羟基]-1H-吡咯-1-基]乙基]-2,2-二甲基 -1,3-二氧戊环-4-乙酸叔丁酯 |
| 阿托伐他汀叔丁酯 |
| 阿托伐他汀甲酯 |
| 阿托伐他汀酸 |
| 阿托伐他汀内酯 |
| 阿托伐他汀甲胺盐 |
| 阿托伐他汀钠 |
| 阿托伐他汀钙 |
| 阿托伐他汀钙无定形 |
| 阿托伐他汀钙晶型Ⅰ |
| 阿托伐他汀钙晶型Ⅷ |
| S-3-氨基-3-苯基丙酸 |
| (S)-β-苯丙氨醇 |
| (S)-γ-二甲氨基-苯丙醇 |
| (±)-γ-二甲氨基-苯丙醇 |
| 消旋达泊西汀游离碱 |
| 达泊西汀游离碱 |
| 达泊西汀盐酸盐 |
| 二异丙基胺基锂 |
| 二乙基甲氧基硼烷四氢呋喃溶液 |
| 六甲基二硅胺基锂四氢呋喃溶液 |
| 正丁基锂己烷溶液 |
| (S)-4-苯基-2-恶唑烷酮 |
| (R)-2-甲基-CBS-恶唑硼烷 |
| (R)-3-(3-甲基-1-氧代丁基)-4-苄基-2-噁唑烷酮 |
| (R)-2,5-二氢-3,6-二乙氧基-2-异丙基吡嗪 |
|
| About Us |
Nangjing Medicine Technology Co.,Ltd.engages in research & development of new drugs, its R&D involves in all kinds of new drugs, focuses on worldwide well-sold brand-name drugs and generic drugs.
We target on new drug research and development (R&D) in Anti-biotics, cancer, Mental drugs and elderly drugs. Combining the characteristic of domestic pharmaceutical enterprise and its own advantages in drug entity development field, Medicinetechnology has developed world class drug such as blood lipid-lowering drugs&intermediate,rennin inhibition&intermediate and so on. and to enhance its process development, especially in the most market demanding field-Anti-biotics API and Intermediate. It is realistic that there are few new drugs possess independent intellectual property in China market. Being ware of this realistic and the high market demand.
Our business philosophy “Good service, Good faith, technical innovation, prime quality”.
We always take security, quality, innovate as first. At the same time, we are interested in collaborating on together.
|
| Contact Us |
Nanjing Medicine Technology Co.,Ltd.
Add：NO.101,Tongtian Road,Technology Park,Jiangning district of Nanjing
Tel：0086-25-66919837
Fax：0086-25-66639600
P.C.：211112
Email: qianqian0914@msn.cn
MSN: qianqian0914@msn.cn
QQ: 392792168
Http://www.mdxpharm.com |
|
